Announcements Trials
Browse Landscape

Status

Completed 3Unknown 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 99Observational 4Expanded_access 1

Sponsor

Cancer Type

Other hematologic neoplasm 15Myeloid 10Sarcoma 4Gastrointestinal 3Tumor-Agnostic 2Lymphoid 2

Conditions

Gastrointestinal Stromal Tumors 3GIST 1

Interventions

Blood Specimen Collection 14Surveys and Questionnaires 13Surgical Procedures, Operative 12Gene Expression Profiling 10Observation 7Amplified Fragment Length Polymorphism Analysis 7Polymerase Chain Reaction 6Drug Therapy 6Radiotherapy 5Microarray Analysis 5Immunohistochemistry 5Psychiatric Rehabilitation 4Imatinib Mesylate 4Base Sequence 4regorafenib 3Trabectedin 3Tissue Banks 3Therapeutics 3Sunitinib 3Specimen Handling 3Reverse Transcriptase Polymerase Chain Reaction 3Radiation 3Methods 3Magnetic Resonance Imaging 3Interviews as Topic 3Doxorubicin 3Biopsy 3ripretinib 2mifamurtide 2Watchful Waiting 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Observational × Imatinib Mesylate × Sarcoma × Clear all
NCT05381753 2026-02-11

Safety and Efficacy of Avapritinib in Chinese Patients With Gastrointestinal Stromal Tumor (GIST) in the Real World

CStone Pharmaceuticals

Completed
61 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT06038552 2025-02-26

Comparison of Clinical Efficacy of Liver Resection, RFA, TACE, and Drug Therapy in Patients with GIST LM

First Affiliated Hospital, Sun Yat-Sen University

Completed
238 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT06628739 2024-10-08

Correlation Between Imatinib Trough Concentration and Efficacy in Advanced GIST Patients with Different Genotypes

First Affiliated Hospital, Sun Yat-Sen University

Completed
168 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT05895942 2023-06-09

EMMBKM

Xijing Hospital

Unknown
190 enrolled
Sarcoma

GIST

Data powered by HemOnc (CC BY 4.0) Colophon âš¡